TRT Testing Requirements: What Labs You Need Before Starting

Testosterone replacement therapy is a medically supervised treatment — and responsible providers require comprehensive lab work before prescribing. The testing process exists to confirm clinical need, establish a baseline for monitoring, and screen for contraindications that could make TRT unsafe.

Understanding what labs are required (and why) helps you prepare for a smoother intake process and evaluate whether a provider is applying the clinical rigor your care deserves.

Why Lab Testing Is Non-Negotiable

TRT is not a lifestyle enhancement that can be prescribed based on symptoms alone. Before treatment begins, a clinician needs objective data to:

• Confirm that testosterone levels are clinically low (not just low-normal)
• Identify potential secondary causes of low T (pituitary, thyroid, or other conditions)
• Screen for contraindications such as polycythemia, active prostate cancer, or severe sleep apnea
• Establish baseline values that allow meaningful monitoring of treatment safety

Any provider that prescribes TRT without baseline labs is not operating within responsible clinical standards — regardless of their marketing language.

Core Hormone Panel

The hormone panel is the foundation of TRT eligibility assessment. Most reputable providers require at least two morning draws to confirm consistently low levels before prescribing.

Required Testosterone Tests

• Total Testosterone: The primary diagnostic marker. Should be drawn in the morning (7–10 AM) when levels are naturally highest. Most clinical guidelines define hypogonadism as total T below 300 ng/dL, though clinical symptoms and context matter.
• Free Testosterone: The biologically active fraction not bound to SHBG or albumin. Some men have normal total T but low free T, particularly with elevated SHBG.
• SHBG (Sex Hormone-Binding Globulin): Affects how much testosterone is bioavailable. High SHBG reduces effective testosterone regardless of total levels.

Related Hormone Testing

• LH and FSH: Luteinizing hormone and follicle-stimulating hormone levels indicate whether low T is primary (testicular) or secondary (pituitary/hypothalamic). This affects treatment approach and fertility considerations.
• Estradiol (E2): Baseline estradiol is essential — testosterone aromatizes to estrogen, and monitoring estradiol is a key part of ongoing TRT management.
• Prolactin: Elevated prolactin can suppress testosterone production and may indicate a pituitary adenoma requiring imaging and specialist referral.

Safety Screening Labs

Blood and Cardiovascular Health

• Complete Blood Count (CBC): Baseline hemoglobin and hematocrit are essential. TRT stimulates red blood cell production, and elevated hematocrit (polycythemia) is one of the primary safety risks to monitor on therapy.
• Lipid Panel: TRT can affect HDL and LDL cholesterol levels. Baseline lipids allow meaningful tracking of any cardiovascular impact.
• Comprehensive Metabolic Panel (CMP): Assesses liver function, kidney function, glucose, and electrolytes — all relevant to TRT safety and metabolic health.

Prostate Health

• PSA (Prostate-Specific Antigen): Baseline PSA is required before TRT in men over 40 and strongly recommended for all men. Active or suspected prostate cancer is a contraindication for TRT. Monitoring PSA annually on therapy is standard practice.

Thyroid Function

• TSH (Thyroid-Stimulating Hormone): Thyroid dysfunction can mimic or contribute to symptoms of low testosterone. Baseline TSH rules out thyroid-driven causes of fatigue, weight gain, and libido changes.

Full Pre-TRT Lab Checklist

At-Home vs. In-Person Lab Testing

Most telehealth TRT providers use one of two approaches for initial lab collection:

• At-Home Test Kits: A finger-prick or small blood draw kit shipped to your home, with results processed by an accredited lab. Convenient, but limited by the panel the kit includes — verify it covers all required markers.
• Lab Order to Patient Service Center: The provider sends a requisition to LabCorp, Quest, or similar, and you visit a local draw location. More comprehensive panels are easier to process this way.

At-home kits have made initial screening more accessible, but always confirm the panel covers all required markers before ordering to avoid delays in your treatment timeline.

Ongoing Monitoring Labs

TRT is not a one-time prescription. Ongoing monitoring is a clinical requirement, not optional. Standard monitoring typically includes:

• Testosterone (total and free), estradiol, and hematocrit at 6–12 weeks after starting or after dose changes
• CBC and PSA every 6–12 months on stable therapy
• Lipid panel annually
• Liver function included in CMP annually

Frequently Asked Questions

How many testosterone readings do I need before starting TRT?

Most clinical guidelines and reputable providers require at least two low testosterone readings, typically on separate mornings. A single low reading can reflect temporary stress, illness, or time of day variation.

Does testing need to be done in the morning?

Yes. Testosterone levels follow a diurnal pattern and are highest in the morning (7–10 AM). Afternoon draws can be 15–30% lower and may not accurately reflect your baseline.

Can I use at-home test kits for TRT labs?

Many providers accept at-home kit results for initial assessment. Verify that the kit panel includes all required markers — particularly LH, FSH, CBC, and PSA — before ordering.

What if my levels are borderline?

Borderline testosterone levels require clinical judgment. A thorough provider will consider your symptoms, free testosterone, SHBG levels, and overall clinical picture rather than making a binary prescribing decision based on total T alone.

How often will I need labs once on TRT?

Standard practice involves labs at 6–12 weeks after initiating or adjusting therapy, then every 6–12 months on stable therapy. Hematocrit monitoring is particularly important due to TRT's effect on red blood cell production.

Compare TRT Programs and Lab Requirements →